Revance Therapeutics Overview
Revance Therapeutics Target Price
Analysts' 12-month price predictions for RVNC.
Share Price
$3.65
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-09-17 | Mizuho SecuritiesVamil Divan | $6.66 |  82.5% upside |  |
| 2024-05-10 | Piper SandlerDavid Amsellem | $11 | 201.4% upside | |
| 2024-05-10 | H.C. WainwrightDouglas Tsao | $11 | 201.4% upside | |
| 2024-05-10 | Mizuho SecuritiesVamil Divan | $8 | 119.2% upside | |
| 2023-09-20 | NeedhamSerge Belanger | $35 | 858.9% upside | |
| 2023-01-10 | Needham | $38 | 941.1% upside | |
| 2022-11-16 | Barclays | $37 | 913.7% upside | |
| 2022-08-25 | Wells FargoJacob Hughes | $24 | 557.5% upside | |